Skip to main content
British Journal of Pharmacology and Chemotherapy logoLink to British Journal of Pharmacology and Chemotherapy
. 1964 Oct;23(2):399–404. doi: 10.1111/j.1476-5381.1964.tb01596.x

Inhibition of sympathomimetic effects on the heart

B G Benfey, D R Varma
PMCID: PMC1704102  PMID: 14228140

Abstract

The adrenaline β-receptor blocking drug, pronethalol, and the sympathomimetic amines, (—)-ephedrine, (—)-amphetamine, dexamphetamine, (—)-Ψ-ephedrine and tyramine, inhibited the sympathomimetic effects of butyrylcholine and tyramine on the guinea-pig isolated atrium. Being reversible and noncompetitive, this antagonism was unspecific and not due to blockade of adrenaline receptors, although pronethalol inhibited the effect of noradrenaline competitively.

Full text

PDF
400

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. ARUNLAKSHANA O., SCHILD H. O. Some quantitative uses of drug antagonists. Br J Pharmacol Chemother. 1959 Mar;14(1):48–58. doi: 10.1111/j.1476-5381.1959.tb00928.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. BENFEY B. G., GREEFF K. Interactions of sympathomimetic drugs and their antagonists on the isolated atrium. Br J Pharmacol Chemother. 1961 Oct;17:232–235. doi: 10.1111/j.1476-5381.1961.tb01283.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. BLACK J. W., STEPHENSON J. S. Pharmacology of a new adrenergic beta-receptor-blocking compound (Nethalide). Lancet. 1962 Aug 18;2(7251):311–314. doi: 10.1016/s0140-6736(62)90103-4. [DOI] [PubMed] [Google Scholar]
  4. FERRY C. B. The synpathomimetic effect of acetylcholine on the spleen of the cat. J Physiol. 1963 Jul;167:487–504. doi: 10.1113/jphysiol.1963.sp007164. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. GILL E. W., WILLIAMS E. M. LOCAL ANAESTHETIC ACTIVITY OF THE BETA-RECEPTOR ANTAGONIST, PRONETHALOL. Nature. 1964 Jan 11;201:199–199. doi: 10.1038/201199a0. [DOI] [PubMed] [Google Scholar]
  6. HOLTZ P., WESTERMANN E. Versuche mit Acetyl-, Propionyl- und Butyrylcholine am isolierten Herzvorhofpräparat. Naunyn Schmiedebergs Arch Exp Pathol Pharmakol. 1955;225(5):421–427. [PubMed] [Google Scholar]
  7. SEKIYA A., VAUGHANWILLIAMS E. M. A COMPARISON OF THE ANTIFIBRILLATORY ACTIONS AND EFFECTS ON INTRACELLULAR CARDIAC POTENTIALS OF PRONETHALOL, DISOPYRAMIDE AND QUINIDINE. Br J Pharmacol Chemother. 1963 Dec;21:473–481. doi: 10.1111/j.1476-5381.1963.tb02015.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. SHANES A. M. Electrochemical aspects of physiological and pharmacological action in excitable cells. II. The action potential and excitation. Pharmacol Rev. 1958 Jun;10(2):165–273. [PubMed] [Google Scholar]
  9. Szekeres L., Williams E. M. Antifibrillatory action. J Physiol. 1962 Mar;160(3):470–482. doi: 10.1113/jphysiol.1962.sp006860. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. TRENDELENBURG U., DELASIERRA B. G., MUSKUS A. MODIFICATION BY RESERPINE OF THE RESPONSE OF THE ATRIAL PACEMAKER TO SYMPATHOMIMETIC AMINES. J Pharmacol Exp Ther. 1963 Sep;141:301–309. [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology and Chemotherapy are provided here courtesy of The British Pharmacological Society

RESOURCES